PPCB Propanc Biopharma, Inc.
NEUTRAL
Impact: 6/10
EFFECT
IPO/offering going effective
Latest settled — T+20d
PPCB ▼ -27.50% at T+20d
NEUTRAL call ✗ call lost -27.50% · α vs SPY -32.41% · entry $2.83 → $2.05
Last close $1.37 (close Jun 8) · -51.55% from $2.83 entry
T+1d
+1.68%
call +1.68% · α +0.66%
$2.88
settled 7w ago
T+5d
-6.28%
call -6.28% · α -7.36%
$2.65
settled 6w ago
T+20d
-27.50%
call -27.50% · α -32.41%
$2.05
settled 22d ago
T+60d
—
call — · α —
—
in 5w
Price Chart
Loading chart...
Executive Summary
Propanc Biopharma's IPO registration has become effective, allowing the company to begin selling shares to the public. This follows the S-1 filing and amendments, marking a key milestone toward potential Nasdaq listing.
Actionable Insight
Monitor for upcoming pricing and trading commencement announcement; absence of disclosed terms means immediate financial impact is limited, but liquidity event is now imminent.
Key Facts
- IPO registration (Form S-1) has become effective as of April 20, 2026
- The company can now legally offer and sell shares to the public
- This is a standard EFFECT notice with no new financial terms disclosed
- Follows prior S-1 and S-1/A filings indicating an upcoming IPO
Financial Impact
IPO offering size and pricing not disclosed in this filing; potential future dilution possible upon share issuance
dilutionmarket_capliquidity
Risk Factors
- Small market cap ($3M) increases volatility risk upon listing
- No disclosed offering size or use of proceeds increases uncertainty
- Biotech pre-revenue profile carries high development and funding risk
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001258 |
| Document: 9999999995-26-001258-index.html | 9999999995-26-001258 |
| Document: 9999999995-26-001258.txt | 9999999995-26-001258 |
8 reports for PPCB
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 19, 2026
21d ago
|
Press Release
| $2.01 $1.62 | ▼ −19.20% | ▼ −21.45% | $1.37 (−31.67%) |
|
May 15, 2026
25d ago
|
Press Release
| $1.70 $1.76 | ▲ +3.53% | ▲ +2.57% | $1.37 (−19.41%) |
|
May 14, 2026
27d ago
|
Press Release
| $1.83 $1.73 | ▼ −5.34% | ▼ −4.62% | $1.37 (−25.03%) |
|
Apr 21, 2026
7w ago
|
EFFECT
| $2.83 $2.65 | ▼ −6.28% | ▼ −7.36% | $1.37 (−51.55%) |
|
Mar 24, 2026
11w ago
|
Press Release
| $2.77 $2.65 | ▼ −4.33% | ▼ −3.91% | $1.37 (−50.54%) |
|
Mar 10, 2026
13w ago
|
Press Release
| $3.42 $2.99 | ▼ −12.65% | ▼ −11.74% | $1.37 (−59.94%) |
|
Mar 3, 2026
14w ago
|
Press Release
| $4.32 $3.42 | ▼ −20.79% | ▼ −20.31% | $1.37 (−68.27%) |
|
Feb 25, 2026
15w ago
|
EFFECT
| $5.04 $4.29 | ▼ −14.79% | ▼ −13.69% | $1.37 (−72.80%) |
Showing 8 of 8
US Market Status
Market Closed — Opens in 7h 22m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access